Search

everythinglearnresearchcommunity

for

Search:↓

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The new delivery method for dutasteride is more effective and has fewer side effects.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

The method accurately measures certain steroids in human hair, showing different levels in males and females.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.